Table 3. WHO-defined COVID-19 symptoms, expressed in prevalence ratios.
Parameter | Intervention effect | Intervention effect by mask type |
No baseline controls | ||
Intervention prevalence ratio | 0.885*** [0.834, 0.934] |
|
Intervention prevalence ratio for surgical mask villages | 0.865*** [0.803, 0.928] |
|
Intervention prevalence ratio for cloth mask villages | 0.922* [0.838, 1.005] |
|
Average symptomatic rate in paired control villages† | 0.0860 | 0.0860 |
With baseline controls | ||
Intervention prevalence ratio | 0.884*** [0.834, 0.934] |
|
Intervention prevalence ratio for surgical mask villages | 0.874*** [0.809, 0.939] |
|
Intervention prevalence ratio for cloth mask villages | 0.907** [0.823, 0.991] |
|
N individuals | 321,948 | 321,948 |
N villages | 572 | 572 |
***Significant at the 1% level.
**Significant at the 5% level.
*Significant at the 10% level.
†We report the mean rate of symptomatic status at endline. This is not equivalent to the coefficient on the constant due to the inclusion of the pair indicators as controls.